acetylglucosamine has been researched along with Cardiovascular Diseases in 22 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 2 (9.09) | 29.6817 |
| 2010's | 16 (72.73) | 24.3611 |
| 2020's | 4 (18.18) | 2.80 |
| Authors | Studies |
|---|---|
| Bakshi, S; Barnes, JW; Benavides, GA; Brahma, MK; Chang, SF; Chatham, JC; Curfman, S; Darley-Usmar, VM; Ha, CM; He, L; Lal, H; Paterson, AJ; Potter, LA; Rajasekaran, NS; Sun, Z; Sunny, S; Umbarkar, P; Wende, AR; Xie, M; Zhang, J; Zou, L | 1 |
| Chatham, JC; Collins, HE | 1 |
| Houttu, N; Koivuniemi, E; Laitinen, K; Mokkala, K; Nielsen, HB; Sørensen, N | 1 |
| Bolanle, IO; Palmer, TM; Riches-Suman, K; Williamson, R | 1 |
| Katakami, N | 1 |
| Connelly, MA; Mehta, NN; Otvos, JD; Playford, MP; Shalaurova, I | 1 |
| Anderson, JL; Connelly, MA; Galenko, O; Knowlton, KU; Lappe, DL; May, HT; Muhlestein, JB; Otvos, JD | 1 |
| Nie, H; Yi, W | 1 |
| Suh, PG; Yang, YR | 1 |
| Caon, I; D'Angelo, ML; De Luca, G; Karousou, E; Moretto, P; Passi, A; Vigetti, D; Viola, M | 1 |
| Deng, Y; Guo, X; Liu, H; Shang, J; Yuan, X; Zhu, D | 1 |
| Hanover, JA; Olivier-Van Stichelen, S | 1 |
| Akinkuolie, AO; Buring, JE; Chandler, PD; Glynn, RJ; Lawler, PR; Lee, IM; Moorthy, MV; Mora, S; Ridker, PM; Schaumberg, DA; Vandenburgh, MJ | 1 |
| Hong, K; Yu, P | 1 |
| Akinkuolie, AO; Glynn, RJ; Mora, S; Padmanabhan, L; Ridker, PM | 1 |
| Dehennaut, V; Drougat, L; Guinez, C; Lefebvre, T; Michalski, JC; Mir, AM; Mortuaire, M; Olivier, S; Vercoutter-Edouart, AS | 1 |
| Facundo, HT; Jones, SP; Ngoh, GA; Zafir, A | 1 |
| Carneiro, FS; Carvalho, MH; Fortes, ZB; Giachini, FR; Lima, VV; Tostes, RC; Webb, RC | 1 |
| Chatham, JC; Marsh, SA | 1 |
| Zachara, NE | 1 |
| Hart, GW; Whelan, SA | 1 |
| Chatham, JC; Fülöp, N; Marchase, RB | 1 |
13 review(s) available for acetylglucosamine and Cardiovascular Diseases
| Article | Year |
|---|---|
Regulation of cardiac O-GlcNAcylation: More than just nutrient availability.
Topics: Acetylglucosamine; Animals; Cardiovascular Diseases; Disease Models, Animal; Feeding Behavior; Heart; Humans; Myocardium; N-Acetylglucosaminyltransferases; Nutrients; Protein Processing, Post-Translational; Stress, Physiological | 2020 |
Emerging roles of protein O-GlcNAcylation in cardiovascular diseases: Insights and novel therapeutic targets.
Topics: Acetylglucosamine; Acetylglucosaminidase; Acylation; Animals; Antigens, Neoplasm; beta-N-Acetylhexosaminidases; Cardiovascular Agents; Cardiovascular Diseases; Drug Delivery Systems; Enzyme Inhibitors; Glycosylation; Histone Acetyltransferases; Humans; Hyaluronoglucosaminidase; N-Acetylglucosaminyltransferases; Protein Processing, Post-Translational | 2021 |
Mechanism of Development of Atherosclerosis and Cardiovascular Disease in Diabetes Mellitus.
Topics: Acetylglucosamine; Animals; Arteries; Atherosclerosis; Cardiovascular Diseases; Diabetes Complications; Disease Progression; Dyslipidemias; Glycation End Products, Advanced; Humans; Hyperglycemia; Hypertension; Inflammation; Insulin Resistance; Mice; Muscle, Smooth, Vascular; Obesity; Oxidative Stress; Polymers; Protein Kinase C; Quality of Life; Reactive Oxygen Species; Risk Factors | 2018 |
GlycA, a novel biomarker of systemic inflammation and cardiovascular disease risk.
Topics: Acetylglucosamine; Biomarkers; C-Reactive Protein; Cardiovascular Diseases; Humans; Inflammation; Risk Factors | 2017 |
O-GlcNAcylation, a sweet link to the pathology of diseases.
Topics: Acetylglucosamine; Animals; Apoptosis; beta-N-Acetylhexosaminidases; Cardiovascular Diseases; Catalysis; Cell Nucleus; Cell Proliferation; Cytoplasm; Diabetes Complications; Diabetes Mellitus, Type 2; Hexosamines; Humans; Insulin; Mitochondria; N-Acetylglucosaminyltransferases; Neoplasms; Neurodegenerative Diseases; Phosphorylation; Protein Processing, Post-Translational; Signal Transduction | 2019 |
O-GlcNAcylation in cellular functions and human diseases.
Topics: Acetylglucosamine; Alzheimer Disease; Animals; Cardiovascular Diseases; Glycosylation; Humans; Signal Transduction | 2014 |
Regulation of hyaluronan synthesis in vascular diseases and diabetes.
Topics: Acetylglucosamine; Acylation; Adenylate Kinase; Animals; Cardiovascular Diseases; Cell Adhesion; Cell Differentiation; Diabetes Mellitus; Gene Expression Regulation, Enzymologic; Humans; Hyaluronic Acid; Inflammation; Microcirculation; Myocytes, Smooth Muscle; Vascular Diseases | 2015 |
You are what you eat: O-linked N-acetylglucosamine in disease, development and epigenetics.
Topics: Acetylglucosamine; Alzheimer Disease; Cardiovascular Diseases; Chromatin; Chronic Disease; Diabetes Mellitus, Type 2; Diet; Epigenesis, Genetic; Feeding Behavior; Female; Gene Expression Regulation; Genetic Loci; Genomic Imprinting; Homeostasis; Humans; Hypothalamo-Hypophyseal System; Lupus Erythematosus, Systemic; N-Acetylglucosaminyltransferases; Neoplasms; Neurogenesis; Obesity; Protein Processing, Post-Translational; X Chromosome Inactivation | 2015 |
Dysregulation of the nutrient/stress sensor O-GlcNAcylation is involved in the etiology of cardiovascular disorders, type-2 diabetes and Alzheimer's disease.
Topics: Acetylglucosamine; Alzheimer Disease; Animals; Basic Helix-Loop-Helix Transcription Factors; Brain; Cardiovascular Diseases; Diabetes Mellitus, Type 2; Forkhead Box Protein O1; Forkhead Transcription Factors; Glucose; Homeodomain Proteins; HSP70 Heat-Shock Proteins; Humans; Insulin Resistance; Myocardial Reperfusion Injury; N-Acetylglucosaminyltransferases; Proteasome Endopeptidase Complex; Trans-Activators; Transcription Factors; Ubiquitins | 2010 |
O-GlcNAc signaling in the cardiovascular system.
Topics: Acetylglucosamine; Acylation; Animals; Cardiovascular Diseases; Cardiovascular System; Cell Cycle; Cell Survival; Diabetes Mellitus; Glycosylation; Humans; Insulin; Myocytes, Cardiac; Phosphorylation; Protein Processing, Post-Translational; Signal Transduction; Stress, Physiological; Transcription, Genetic | 2010 |
The roles of O-linked β-N-acetylglucosamine in cardiovascular physiology and disease.
Topics: Acetylglucosamine; Animals; Cardiovascular Diseases; Cardiovascular Physiological Phenomena; Humans; Hyperglycemia; Hypertension; Phosphorylation; Protein Processing, Post-Translational | 2012 |
Proteomic approaches to analyze the dynamic relationships between nucleocytoplasmic protein glycosylation and phosphorylation.
Topics: Acetylglucosamine; Acetylglucosaminidase; Animals; beta-N-Acetylhexosaminidases; Cardiovascular Diseases; Cell Nucleus; Cytoplasm; Dithiothreitol; Glycosylation; Hexosamines; Histone Acetyltransferases; Humans; Multienzyme Complexes; N-Acetylglucosaminyltransferases; Phosphorylation; Protein Processing, Post-Translational; Proteins; Proteomics | 2003 |
Role of protein O-linked N-acetyl-glucosamine in mediating cell function and survival in the cardiovascular system.
Topics: Acetylglucosamine; Animals; Cardiovascular Diseases; Cell Survival; Diabetes Mellitus, Type 2; Glucose; Glycosylation; Hexosamines; Humans; Myocytes, Cardiac; Signal Transduction | 2007 |
1 trial(s) available for acetylglucosamine and Cardiovascular Diseases
| Article | Year |
|---|---|
Circulating N-Linked Glycoprotein Side-Chain Biomarker, Rosuvastatin Therapy, and Incident Cardiovascular Disease: An Analysis From the JUPITER Trial.
Topics: Acetylglucosamine; Aged; Anticholesteremic Agents; Biomarkers; C-Reactive Protein; Cardiovascular Diseases; Double-Blind Method; Female; Humans; Male; Middle Aged; Risk; Rosuvastatin Calcium | 2016 |
8 other study(ies) available for acetylglucosamine and Cardiovascular Diseases
| Article | Year |
|---|---|
Sustained Increases in Cardiomyocyte Protein
Topics: Acetylglucosamine; Animals; Cardiomegaly; Cardiovascular Diseases; Disease Models, Animal; Glycosylation; Mice; Mitochondria; Myocytes, Cardiac; N-Acetylglucosaminyltransferases; Protein Processing, Post-Translational | 2023 |
GlycA, a novel marker for low grade inflammation, reflects gut microbiome diversity and is more accurate than high sensitive CRP in reflecting metabolomic profile.
Topics: Acetylglucosamine; Adult; Biomarkers; C-Reactive Protein; Cardiovascular Diseases; Cross-Sectional Studies; Feces; Female; Fibrinogen; Gastrointestinal Microbiome; Glycoproteins; Haptoglobins; Humans; Inflammation; Metabolomics; Obesity; Pregnancy; Serum Amyloid A Protein | 2020 |
GlycA and hsCRP are independent and additive predictors of future cardiovascular events among patients undergoing angiography: The intermountain heart collaborative study.
Topics: Acetylglucosamine; Aged; Biomarkers; C-Reactive Protein; Cardiovascular Diseases; Coronary Angiography; Coronary Artery Disease; Enzyme-Linked Immunosorbent Assay; Female; Follow-Up Studies; Glucosamine; Glycoproteins; Humans; Inflammation; Magnetic Resonance Spectroscopy; Male; Middle Aged; Prognosis; Proportional Hazards Models; Risk Assessment | 2018 |
Alterations in left ventricular function during intermittent hypoxia: Possible involvement of O-GlcNAc protein and MAPK signaling.
Topics: Acetylglucosamine; Animals; Apoptosis; Blood Gas Analysis; Blood Pressure; Calcium-Calmodulin-Dependent Protein Kinase Type 2; Cardiovascular Diseases; Caspase 3; Cell Hypoxia; Extracellular Signal-Regulated MAP Kinases; In Situ Nick-End Labeling; Interleukin-6; Male; MAP Kinase Signaling System; Myocardium; Myocytes, Cardiac; N-Acetylglucosaminyltransferases; NF-kappa B; p38 Mitogen-Activated Protein Kinases; Phosphorylation; Rats; Rats, Wistar; Sleep Apnea, Obstructive; Tumor Necrosis Factor-alpha; Ventricular Function, Left | 2015 |
Circulating N-Linked Glycoprotein Acetyls and Longitudinal Mortality Risk.
Topics: Acetylgalactosamine; Acetylglucosamine; Acute-Phase Proteins; Aged; Biomarkers; Blood Proteins; C-Reactive Protein; Cardiovascular Diseases; Cause of Death; Female; Follow-Up Studies; Glycoproteins; Humans; Hydroxymethylglutaryl-CoA Reductase Inhibitors; Inflammation; Kaplan-Meier Estimate; Lipids; Male; Middle Aged; Mortality; Neoplasms; Nuclear Magnetic Resonance, Biomolecular; Polysaccharides; Proportional Hazards Models; Randomized Controlled Trials as Topic; Reproducibility of Results; Retrospective Studies; Risk | 2016 |
[Research advances on the relationship between O-linked N-acetylglucosamine and cardiovascular diseases].
Topics: Acetylglucosamine; Cardiovascular Diseases; Humans | 2016 |
O-GlcNAcylation contributes to the vascular effects of ET-1 via activation of the RhoA/Rho-kinase pathway.
Topics: Acetylglucosamine; Acylation; Animals; Aorta, Thoracic; Cardiovascular Diseases; Cells, Cultured; Endothelin-1; Male; Muscle, Smooth, Vascular; Phosphorylation; Rats; Rats, Wistar; rho-Associated Kinases; rhoA GTP-Binding Protein; Signal Transduction; Vasoconstriction | 2011 |
The paradoxical world of protein O-GlcNAcylation: a novel effector of cardiovascular (dys)function.
Topics: Acetylglucosamine; Acylation; Animals; Cardiovascular Diseases; Endothelin-1; Humans; rho-Associated Kinases | 2011 |